The article proposes a potential solution to COVID-19 by finding and using a naturally attenuated strain of the SARS-CoV-2 virus, which would be less pathogenic but still provide immunity. The author suggests that such a strain could be found by sequencing the virus from asymptomatic or mildly infected individuals. This approach is compared to the use of live attenuated vaccines for other diseases, such as polio. The goal is to find a strain that can be used to inoculate people, providing immunity without causing serious illness.